Junichi Sasaki

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

Mitsuhiro Yokoyama, Hideki Origasa, Masunori Matsuzaki et al. · The Lancet · 2007 · 2.5K citations

Metabolic Syndrome, Hypercholesterolaemic Patients, Cardiovascular Disease +8

Does superoxide underlie the pathogenesis of hypertension?

Kazutoshi Nakazono, Nozomi Watanabe, Kenjiro Matsuno et al. · Proceedings of the National Academy of Sciences · 1991 · 748 citations · Full text

Inflammation, Hypertension, Cardiovascular Disease +15

Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan ^|^mdash;2012 Version

Tamio Teramoto, Junichi Sasaki, Shun Ishibashi et al. · Journal of Atherosclerosis and Thrombosis · 2013 · 463 citations · Full text

Hypertension, Vascular Disease, Japan Atherosclerosis Society +20

Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)

Yasushi Saitō, Mitsuhiro Yokoyama, Hideki Origasa et al. · Atherosclerosis · 2008 · 318 citations

Hypercholesterolemic Patients, Cardiovascular Disease, Health Policy +9

Large Scale Cohort Study of the Relationship Between Serum Cholesterol Concentration and Coronary Events With Low-Dose Simvastatin Therapy in Japanese Patients With Hypercholesterolemia. Primary Prevention Cohort Study of the Japan Lipid Intervention Trial (J-LIT).

Masunori Matsuzaki, Toru Kita, Hiroshi Mabuchi et al. · Circulation Journal · 2002 · 261 citations · Full text